nodes	percent_of_prediction	percent_of_DWPC	metapath
Cyclosporine—P-Glycoprotein Inhibitors—Vemurafenib—skin cancer	0.422	1	CiPCiCtD
Cyclosporine—psoriasis—skin cancer	0.281	1	CtDrD
Cyclosporine—ABCC1—Vemurafenib—skin cancer	0.0202	0.101	CbGbCtD
Cyclosporine—ABCC10—Docetaxel—skin cancer	0.0179	0.0895	CbGbCtD
Cyclosporine—ABCG2—Vismodegib—skin cancer	0.0171	0.0852	CbGbCtD
Cyclosporine—ABCC3—Fluorouracil—skin cancer	0.0148	0.0737	CbGbCtD
Cyclosporine—ABCG2—Vemurafenib—skin cancer	0.0135	0.0674	CbGbCtD
Cyclosporine—ABCC1—Dactinomycin—skin cancer	0.0134	0.0669	CbGbCtD
Cyclosporine—CYP2C8—Vismodegib—skin cancer	0.00909	0.0454	CbGbCtD
Cyclosporine—ABCG2—Dactinomycin—skin cancer	0.00896	0.0448	CbGbCtD
Cyclosporine—CYP2C19—Vismodegib—skin cancer	0.00763	0.0381	CbGbCtD
Cyclosporine—ABCC1—Docetaxel—skin cancer	0.00692	0.0345	CbGbCtD
Cyclosporine—CYP2C9—Vismodegib—skin cancer	0.00634	0.0317	CbGbCtD
Cyclosporine—ABCB1—Vismodegib—skin cancer	0.00615	0.0307	CbGbCtD
Cyclosporine—ABCG2—Fluorouracil—skin cancer	0.00606	0.0303	CbGbCtD
Cyclosporine—CYP3A4—Imiquimod—skin cancer	0.00532	0.0266	CbGbCtD
Cyclosporine—CYP3A4—Temozolomide—skin cancer	0.00532	0.0266	CbGbCtD
Cyclosporine—ABCC2—Docetaxel—skin cancer	0.00512	0.0256	CbGbCtD
Cyclosporine—ABCG2—Docetaxel—skin cancer	0.00463	0.0231	CbGbCtD
Cyclosporine—CYP2D6—Vemurafenib—skin cancer	0.00458	0.0229	CbGbCtD
Cyclosporine—CYP3A4—Vismodegib—skin cancer	0.00369	0.0184	CbGbCtD
Cyclosporine—CYP3A7-CYP3A51P—Docetaxel—skin cancer	0.00342	0.0171	CbGbCtD
Cyclosporine—CYP3A7—Docetaxel—skin cancer	0.00342	0.0171	CbGbCtD
Cyclosporine—ABCB1—Dactinomycin—skin cancer	0.00323	0.0161	CbGbCtD
Cyclosporine—CYP2C8—Fluorouracil—skin cancer	0.00323	0.0161	CbGbCtD
Cyclosporine—CYP3A4—Vemurafenib—skin cancer	0.00291	0.0146	CbGbCtD
Cyclosporine—CYP3A5—Docetaxel—skin cancer	0.00256	0.0128	CbGbCtD
Cyclosporine—CYP2C9—Fluorouracil—skin cancer	0.00225	0.0112	CbGbCtD
Cyclosporine—ABCB1—Docetaxel—skin cancer	0.00167	0.00833	CbGbCtD
Cyclosporine—FKBP4—hair follicle—skin cancer	0.00113	0.0431	CbGeAlD
Cyclosporine—CAMLG—hair follicle—skin cancer	0.00103	0.0393	CbGeAlD
Cyclosporine—PPP3R2—female reproductive system—skin cancer	0.00101	0.0385	CbGeAlD
Cyclosporine—CYP3A4—Docetaxel—skin cancer	0.001	0.00499	CbGbCtD
Cyclosporine—PPIF—hair follicle—skin cancer	0.000758	0.029	CbGeAlD
Cyclosporine—PPP3CA—hair follicle—skin cancer	0.000726	0.0277	CbGeAlD
Cyclosporine—PPIB—hair follicle—skin cancer	0.000722	0.0276	CbGeAlD
Cyclosporine—PPID—nipple—skin cancer	0.000707	0.027	CbGeAlD
Cyclosporine—CAMLG—nipple—skin cancer	0.000697	0.0266	CbGeAlD
Cyclosporine—PPIA—nipple—skin cancer	0.000635	0.0242	CbGeAlD
Cyclosporine—FKBP4—connective tissue—skin cancer	0.000543	0.0207	CbGeAlD
Cyclosporine—PPIF—nipple—skin cancer	0.000514	0.0196	CbGeAlD
Cyclosporine—PPP3CA—nipple—skin cancer	0.000492	0.0188	CbGeAlD
Cyclosporine—FKBP4—skin of body—skin cancer	0.000491	0.0187	CbGeAlD
Cyclosporine—PPIB—nipple—skin cancer	0.000489	0.0187	CbGeAlD
Cyclosporine—PPIB—neck—skin cancer	0.000484	0.0185	CbGeAlD
Cyclosporine—FKBP1B—head—skin cancer	0.000484	0.0185	CbGeAlD
Cyclosporine—PPID—mammalian vulva—skin cancer	0.000413	0.0158	CbGeAlD
Cyclosporine—CAMLG—mammalian vulva—skin cancer	0.000407	0.0155	CbGeAlD
Cyclosporine—FKBP4—lymphoid tissue—skin cancer	0.000397	0.0152	CbGeAlD
Cyclosporine—FKBP4—female reproductive system—skin cancer	0.000383	0.0146	CbGeAlD
Cyclosporine—PPIA—mammalian vulva—skin cancer	0.000371	0.0142	CbGeAlD
Cyclosporine—CAMLG—lymphoid tissue—skin cancer	0.000361	0.0138	CbGeAlD
Cyclosporine—PPID—female reproductive system—skin cancer	0.000354	0.0135	CbGeAlD
Cyclosporine—PPP3CA—connective tissue—skin cancer	0.000349	0.0133	CbGeAlD
Cyclosporine—CAMLG—female reproductive system—skin cancer	0.000349	0.0133	CbGeAlD
Cyclosporine—PPIB—connective tissue—skin cancer	0.000347	0.0133	CbGeAlD
Cyclosporine—FKBP1B—lymph node—skin cancer	0.000339	0.0129	CbGeAlD
Cyclosporine—PPIB—epithelium—skin cancer	0.000329	0.0126	CbGeAlD
Cyclosporine—PPIF—skin of body—skin cancer	0.000329	0.0126	CbGeAlD
Cyclosporine—FKBP1A—nipple—skin cancer	0.000327	0.0125	CbGeAlD
Cyclosporine—FKBP1A—neck—skin cancer	0.000324	0.0124	CbGeAlD
Cyclosporine—FKBP4—head—skin cancer	0.00032	0.0122	CbGeAlD
Cyclosporine—PPIB—skin of body—skin cancer	0.000313	0.012	CbGeAlD
Cyclosporine—PPIF—mammalian vulva—skin cancer	0.0003	0.0115	CbGeAlD
Cyclosporine—PPID—head—skin cancer	0.000295	0.0113	CbGeAlD
Cyclosporine—CAMLG—head—skin cancer	0.000291	0.0111	CbGeAlD
Cyclosporine—PPP3CA—mammalian vulva—skin cancer	0.000287	0.011	CbGeAlD
Cyclosporine—PPIB—mammalian vulva—skin cancer	0.000286	0.0109	CbGeAlD
Cyclosporine—ABCC1—hair follicle—skin cancer	0.000273	0.0104	CbGeAlD
Cyclosporine—ABCC10—nipple—skin cancer	0.000262	0.01	CbGeAlD
Cyclosporine—PPIF—female reproductive system—skin cancer	0.000257	0.00982	CbGeAlD
Cyclosporine—PPP3CA—lymphoid tissue—skin cancer	0.000255	0.00975	CbGeAlD
Cyclosporine—PPIB—lymphoid tissue—skin cancer	0.000254	0.00969	CbGeAlD
Cyclosporine—PPP3CA—female reproductive system—skin cancer	0.000246	0.0094	CbGeAlD
Cyclosporine—PPIB—female reproductive system—skin cancer	0.000245	0.00935	CbGeAlD
Cyclosporine—FKBP1A—connective tissue—skin cancer	0.000232	0.00886	CbGeAlD
Cyclosporine—FKBP4—lymph node—skin cancer	0.000224	0.00856	CbGeAlD
Cyclosporine—FKBP1A—epithelium—skin cancer	0.00022	0.00841	CbGeAlD
Cyclosporine—PPIF—head—skin cancer	0.000215	0.0082	CbGeAlD
Cyclosporine—FKBP1A—skin of body—skin cancer	0.000209	0.008	CbGeAlD
Cyclosporine—SLC10A1—female reproductive system—skin cancer	0.000209	0.00799	CbGeAlD
Cyclosporine—PPID—lymph node—skin cancer	0.000207	0.0079	CbGeAlD
Cyclosporine—PPP3CA—head—skin cancer	0.000206	0.00785	CbGeAlD
Cyclosporine—PPIB—head—skin cancer	0.000204	0.00781	CbGeAlD
Cyclosporine—CAMLG—lymph node—skin cancer	0.000204	0.00779	CbGeAlD
Cyclosporine—FKBP1A—mammalian vulva—skin cancer	0.000191	0.00729	CbGeAlD
Cyclosporine—PPIA—lymph node—skin cancer	0.000186	0.00709	CbGeAlD
Cyclosporine—ABCC1—nipple—skin cancer	0.000185	0.00708	CbGeAlD
Cyclosporine—SLC10A1—head—skin cancer	0.000175	0.00668	CbGeAlD
Cyclosporine—FKBP1A—lymphoid tissue—skin cancer	0.00017	0.00648	CbGeAlD
Cyclosporine—FKBP1A—female reproductive system—skin cancer	0.000164	0.00625	CbGeAlD
Cyclosporine—ABCC10—mammalian vulva—skin cancer	0.000153	0.00584	CbGeAlD
Cyclosporine—PPIF—lymph node—skin cancer	0.00015	0.00574	CbGeAlD
Cyclosporine—PPP3CA—lymph node—skin cancer	0.000144	0.0055	CbGeAlD
Cyclosporine—PPIB—lymph node—skin cancer	0.000143	0.00547	CbGeAlD
Cyclosporine—SLCO1B1—female reproductive system—skin cancer	0.000139	0.0053	CbGeAlD
Cyclosporine—FKBP1A—head—skin cancer	0.000137	0.00522	CbGeAlD
Cyclosporine—ABCC10—lymphoid tissue—skin cancer	0.000136	0.00519	CbGeAlD
Cyclosporine—ABCC3—female reproductive system—skin cancer	0.000132	0.00503	CbGeAlD
Cyclosporine—ABCC10—female reproductive system—skin cancer	0.000131	0.005	CbGeAlD
Cyclosporine—ABCC3—head—skin cancer	0.00011	0.0042	CbGeAlD
Cyclosporine—ABCC1—mammalian vulva—skin cancer	0.000108	0.00413	CbGeAlD
Cyclosporine—ABCC2—female reproductive system—skin cancer	0.000105	0.00402	CbGeAlD
Cyclosporine—ABCB1—blood vessel—skin cancer	0.000105	0.004	CbGeAlD
Cyclosporine—FKBP1A—lymph node—skin cancer	9.57e-05	0.00365	CbGeAlD
Cyclosporine—SLCO1A2—head—skin cancer	9.43e-05	0.0036	CbGeAlD
Cyclosporine—ABCG2—mammalian vulva—skin cancer	8.96e-05	0.00342	CbGeAlD
Cyclosporine—CYP2C8—female reproductive system—skin cancer	7.89e-05	0.00301	CbGeAlD
Cyclosporine—ABCC3—lymph node—skin cancer	7.7e-05	0.00294	CbGeAlD
Cyclosporine—ABCC10—lymph node—skin cancer	7.66e-05	0.00293	CbGeAlD
Cyclosporine—CYP2C9—female reproductive system—skin cancer	7.01e-05	0.00268	CbGeAlD
Cyclosporine—ABCC2—lymph node—skin cancer	6.15e-05	0.00235	CbGeAlD
Cyclosporine—ABCC1—lymph node—skin cancer	5.42e-05	0.00207	CbGeAlD
Cyclosporine—CYP3A4—female reproductive system—skin cancer	5.34e-05	0.00204	CbGeAlD
Cyclosporine—CYP2D6—female reproductive system—skin cancer	5.26e-05	0.00201	CbGeAlD
Cyclosporine—ABCB1—epithelium—skin cancer	5.09e-05	0.00194	CbGeAlD
Cyclosporine—Leukopenia—Bleomycin—skin cancer	5.05e-05	0.00084	CcSEcCtD
Cyclosporine—Rhinitis—Fluorouracil—skin cancer	5.05e-05	0.00084	CcSEcCtD
Cyclosporine—Haemorrhage—Fluorouracil—skin cancer	5.04e-05	0.000838	CcSEcCtD
Cyclosporine—Dizziness—Vemurafenib—skin cancer	5.03e-05	0.000836	CcSEcCtD
Cyclosporine—Hypoaesthesia—Fluorouracil—skin cancer	5.01e-05	0.000834	CcSEcCtD
Cyclosporine—Pharyngitis—Fluorouracil—skin cancer	5e-05	0.000832	CcSEcCtD
Cyclosporine—Angiopathy—Temozolomide—skin cancer	4.96e-05	0.000825	CcSEcCtD
Cyclosporine—Mediastinal disorder—Temozolomide—skin cancer	4.93e-05	0.00082	CcSEcCtD
Cyclosporine—Cough—Bleomycin—skin cancer	4.93e-05	0.000819	CcSEcCtD
Cyclosporine—Chills—Temozolomide—skin cancer	4.91e-05	0.000816	CcSEcCtD
Cyclosporine—Ill-defined disorder—Dactinomycin—skin cancer	4.88e-05	0.000812	CcSEcCtD
Cyclosporine—Anaemia—Dactinomycin—skin cancer	4.87e-05	0.000809	CcSEcCtD
Cyclosporine—Vomiting—Vemurafenib—skin cancer	4.83e-05	0.000804	CcSEcCtD
Cyclosporine—Alopecia—Temozolomide—skin cancer	4.83e-05	0.000804	CcSEcCtD
Cyclosporine—Dry skin—Docetaxel—skin cancer	4.82e-05	0.000801	CcSEcCtD
Cyclosporine—Myalgia—Bleomycin—skin cancer	4.81e-05	0.000799	CcSEcCtD
Cyclosporine—Chest pain—Bleomycin—skin cancer	4.81e-05	0.000799	CcSEcCtD
Cyclosporine—Abdominal pain upper—Docetaxel—skin cancer	4.8e-05	0.000799	CcSEcCtD
Cyclosporine—Rash—Vemurafenib—skin cancer	4.79e-05	0.000797	CcSEcCtD
Cyclosporine—Mental disorder—Temozolomide—skin cancer	4.79e-05	0.000797	CcSEcCtD
Cyclosporine—Dermatitis—Vemurafenib—skin cancer	4.79e-05	0.000796	CcSEcCtD
Cyclosporine—Hypersensitivity—Imiquimod—skin cancer	4.78e-05	0.000794	CcSEcCtD
Cyclosporine—Headache—Vemurafenib—skin cancer	4.76e-05	0.000792	CcSEcCtD
Cyclosporine—Malnutrition—Temozolomide—skin cancer	4.76e-05	0.000792	CcSEcCtD
Cyclosporine—Breast disorder—Docetaxel—skin cancer	4.75e-05	0.00079	CcSEcCtD
Cyclosporine—Discomfort—Bleomycin—skin cancer	4.75e-05	0.000789	CcSEcCtD
Cyclosporine—Malaise—Dactinomycin—skin cancer	4.75e-05	0.000789	CcSEcCtD
Cyclosporine—Cramp muscle—Docetaxel—skin cancer	4.73e-05	0.000787	CcSEcCtD
Cyclosporine—Leukopenia—Dactinomycin—skin cancer	4.71e-05	0.000784	CcSEcCtD
Cyclosporine—Dysgeusia—Temozolomide—skin cancer	4.66e-05	0.000775	CcSEcCtD
Cyclosporine—Asthenia—Imiquimod—skin cancer	4.65e-05	0.000774	CcSEcCtD
Cyclosporine—Confusional state—Bleomycin—skin cancer	4.64e-05	0.000772	CcSEcCtD
Cyclosporine—Oedema—Bleomycin—skin cancer	4.61e-05	0.000766	CcSEcCtD
Cyclosporine—Anaphylactic shock—Bleomycin—skin cancer	4.61e-05	0.000766	CcSEcCtD
Cyclosporine—Pruritus—Imiquimod—skin cancer	4.59e-05	0.000763	CcSEcCtD
Cyclosporine—Infection—Bleomycin—skin cancer	4.58e-05	0.000761	CcSEcCtD
Cyclosporine—Dysphagia—Docetaxel—skin cancer	4.54e-05	0.000756	CcSEcCtD
Cyclosporine—Nausea—Vemurafenib—skin cancer	4.52e-05	0.000751	CcSEcCtD
Cyclosporine—Thrombocytopenia—Bleomycin—skin cancer	4.51e-05	0.00075	CcSEcCtD
Cyclosporine—Arrhythmia—Fluorouracil—skin cancer	4.5e-05	0.000749	CcSEcCtD
Cyclosporine—ABCG2—lymph node—skin cancer	4.49e-05	0.00171	CbGeAlD
Cyclosporine—Vision blurred—Temozolomide—skin cancer	4.49e-05	0.000746	CcSEcCtD
Cyclosporine—Myalgia—Dactinomycin—skin cancer	4.48e-05	0.000745	CcSEcCtD
Cyclosporine—Bronchospasm—Docetaxel—skin cancer	4.47e-05	0.000743	CcSEcCtD
Cyclosporine—Tremor—Temozolomide—skin cancer	4.46e-05	0.000742	CcSEcCtD
Cyclosporine—Alopecia—Fluorouracil—skin cancer	4.45e-05	0.00074	CcSEcCtD
Cyclosporine—Diarrhoea—Imiquimod—skin cancer	4.44e-05	0.000738	CcSEcCtD
Cyclosporine—Discomfort—Dactinomycin—skin cancer	4.43e-05	0.000736	CcSEcCtD
Cyclosporine—Ill-defined disorder—Temozolomide—skin cancer	4.42e-05	0.000735	CcSEcCtD
Cyclosporine—ABCB1—mammalian vulva—skin cancer	4.42e-05	0.00169	CbGeAlD
Cyclosporine—Anaemia—Temozolomide—skin cancer	4.4e-05	0.000732	CcSEcCtD
Cyclosporine—CYP2D6—head—skin cancer	4.39e-05	0.00168	CbGeAlD
Cyclosporine—Anorexia—Bleomycin—skin cancer	4.39e-05	0.00073	CcSEcCtD
Cyclosporine—Agitation—Temozolomide—skin cancer	4.38e-05	0.000728	CcSEcCtD
Cyclosporine—Angioedema—Temozolomide—skin cancer	4.35e-05	0.000723	CcSEcCtD
Cyclosporine—Oedema—Dactinomycin—skin cancer	4.3e-05	0.000714	CcSEcCtD
Cyclosporine—Malaise—Temozolomide—skin cancer	4.29e-05	0.000714	CcSEcCtD
Cyclosporine—Dizziness—Imiquimod—skin cancer	4.29e-05	0.000713	CcSEcCtD
Cyclosporine—Vertigo—Temozolomide—skin cancer	4.28e-05	0.000711	CcSEcCtD
Cyclosporine—Infection—Dactinomycin—skin cancer	4.27e-05	0.00071	CcSEcCtD
Cyclosporine—Leukopenia—Temozolomide—skin cancer	4.26e-05	0.000709	CcSEcCtD
Cyclosporine—Thrombocytopenia—Dactinomycin—skin cancer	4.21e-05	0.000699	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Bleomycin—skin cancer	4.2e-05	0.000698	CcSEcCtD
Cyclosporine—Cough—Temozolomide—skin cancer	4.15e-05	0.000691	CcSEcCtD
Cyclosporine—Paraesthesia—Bleomycin—skin cancer	4.14e-05	0.000688	CcSEcCtD
Cyclosporine—Weight increased—Docetaxel—skin cancer	4.14e-05	0.000688	CcSEcCtD
Cyclosporine—Vision blurred—Fluorouracil—skin cancer	4.13e-05	0.000687	CcSEcCtD
Cyclosporine—Convulsion—Temozolomide—skin cancer	4.13e-05	0.000686	CcSEcCtD
Cyclosporine—Vomiting—Imiquimod—skin cancer	4.12e-05	0.000686	CcSEcCtD
Cyclosporine—Weight decreased—Docetaxel—skin cancer	4.11e-05	0.000684	CcSEcCtD
Cyclosporine—Hypertension—Temozolomide—skin cancer	4.11e-05	0.000684	CcSEcCtD
Cyclosporine—Dyspnoea—Bleomycin—skin cancer	4.11e-05	0.000683	CcSEcCtD
Cyclosporine—Anorexia—Dactinomycin—skin cancer	4.1e-05	0.000681	CcSEcCtD
Cyclosporine—Rash—Imiquimod—skin cancer	4.09e-05	0.00068	CcSEcCtD
Cyclosporine—Dermatitis—Imiquimod—skin cancer	4.08e-05	0.000679	CcSEcCtD
Cyclosporine—Pneumonia—Docetaxel—skin cancer	4.08e-05	0.000678	CcSEcCtD
Cyclosporine—Headache—Imiquimod—skin cancer	4.06e-05	0.000675	CcSEcCtD
Cyclosporine—Anaemia—Fluorouracil—skin cancer	4.05e-05	0.000674	CcSEcCtD
Cyclosporine—Arthralgia—Temozolomide—skin cancer	4.05e-05	0.000674	CcSEcCtD
Cyclosporine—Myalgia—Temozolomide—skin cancer	4.05e-05	0.000674	CcSEcCtD
Cyclosporine—Infestation—Docetaxel—skin cancer	4.05e-05	0.000674	CcSEcCtD
Cyclosporine—Infestation NOS—Docetaxel—skin cancer	4.05e-05	0.000674	CcSEcCtD
Cyclosporine—Anxiety—Temozolomide—skin cancer	4.04e-05	0.000672	CcSEcCtD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—skin cancer	4.03e-05	0.000669	CcSEcCtD
Cyclosporine—Discomfort—Temozolomide—skin cancer	4e-05	0.000666	CcSEcCtD
Cyclosporine—Decreased appetite—Bleomycin—skin cancer	4e-05	0.000666	CcSEcCtD
Cyclosporine—Acute coronary syndrome—Docetaxel—skin cancer	3.99e-05	0.000664	CcSEcCtD
Cyclosporine—Renal failure—Docetaxel—skin cancer	3.98e-05	0.000662	CcSEcCtD
Cyclosporine—Myocardial infarction—Docetaxel—skin cancer	3.97e-05	0.00066	CcSEcCtD
Cyclosporine—Neuropathy peripheral—Docetaxel—skin cancer	3.97e-05	0.00066	CcSEcCtD
Cyclosporine—Dry mouth—Temozolomide—skin cancer	3.96e-05	0.000659	CcSEcCtD
Cyclosporine—Stomatitis—Docetaxel—skin cancer	3.95e-05	0.000657	CcSEcCtD
Cyclosporine—Jaundice—Docetaxel—skin cancer	3.95e-05	0.000657	CcSEcCtD
Cyclosporine—Pain—Bleomycin—skin cancer	3.94e-05	0.000655	CcSEcCtD
Cyclosporine—Conjunctivitis—Docetaxel—skin cancer	3.94e-05	0.000655	CcSEcCtD
Cyclosporine—Leukopenia—Fluorouracil—skin cancer	3.93e-05	0.000653	CcSEcCtD
Cyclosporine—ABCB1—lymphoid tissue—skin cancer	3.92e-05	0.0015	CbGeAlD
Cyclosporine—Confusional state—Temozolomide—skin cancer	3.92e-05	0.000652	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Dactinomycin—skin cancer	3.91e-05	0.000651	CcSEcCtD
Cyclosporine—Anaphylactic shock—Temozolomide—skin cancer	3.89e-05	0.000646	CcSEcCtD
Cyclosporine—Oedema—Temozolomide—skin cancer	3.89e-05	0.000646	CcSEcCtD
Cyclosporine—Infection—Temozolomide—skin cancer	3.86e-05	0.000642	CcSEcCtD
Cyclosporine—Nausea—Imiquimod—skin cancer	3.85e-05	0.00064	CcSEcCtD
Cyclosporine—Hepatobiliary disease—Docetaxel—skin cancer	3.83e-05	0.000637	CcSEcCtD
Cyclosporine—Epistaxis—Docetaxel—skin cancer	3.82e-05	0.000635	CcSEcCtD
Cyclosporine—Nervous system disorder—Temozolomide—skin cancer	3.81e-05	0.000634	CcSEcCtD
Cyclosporine—Thrombocytopenia—Temozolomide—skin cancer	3.8e-05	0.000633	CcSEcCtD
Cyclosporine—Convulsion—Fluorouracil—skin cancer	3.8e-05	0.000632	CcSEcCtD
Cyclosporine—Feeling abnormal—Bleomycin—skin cancer	3.8e-05	0.000631	CcSEcCtD
Cyclosporine—ABCB1—female reproductive system—skin cancer	3.78e-05	0.00144	CbGeAlD
Cyclosporine—Skin disorder—Temozolomide—skin cancer	3.77e-05	0.000628	CcSEcCtD
Cyclosporine—Hyperhidrosis—Temozolomide—skin cancer	3.76e-05	0.000625	CcSEcCtD
Cyclosporine—Chest pain—Fluorouracil—skin cancer	3.73e-05	0.000621	CcSEcCtD
Cyclosporine—Myalgia—Fluorouracil—skin cancer	3.73e-05	0.000621	CcSEcCtD
Cyclosporine—Decreased appetite—Dactinomycin—skin cancer	3.73e-05	0.000621	CcSEcCtD
Cyclosporine—Fatigue—Dactinomycin—skin cancer	3.7e-05	0.000616	CcSEcCtD
Cyclosporine—Anorexia—Temozolomide—skin cancer	3.7e-05	0.000616	CcSEcCtD
Cyclosporine—Discomfort—Fluorouracil—skin cancer	3.69e-05	0.000614	CcSEcCtD
Cyclosporine—Pain—Dactinomycin—skin cancer	3.67e-05	0.000611	CcSEcCtD
Cyclosporine—Urticaria—Bleomycin—skin cancer	3.66e-05	0.000609	CcSEcCtD
Cyclosporine—Haemoglobin—Docetaxel—skin cancer	3.66e-05	0.000608	CcSEcCtD
Cyclosporine—Rhinitis—Docetaxel—skin cancer	3.65e-05	0.000606	CcSEcCtD
Cyclosporine—Body temperature increased—Bleomycin—skin cancer	3.64e-05	0.000606	CcSEcCtD
Cyclosporine—Haemorrhage—Docetaxel—skin cancer	3.64e-05	0.000605	CcSEcCtD
Cyclosporine—Hepatitis—Docetaxel—skin cancer	3.64e-05	0.000605	CcSEcCtD
Cyclosporine—Hypoaesthesia—Docetaxel—skin cancer	3.62e-05	0.000602	CcSEcCtD
Cyclosporine—Confusional state—Fluorouracil—skin cancer	3.61e-05	0.0006	CcSEcCtD
Cyclosporine—Pharyngitis—Docetaxel—skin cancer	3.61e-05	0.0006	CcSEcCtD
Cyclosporine—Urinary tract disorder—Docetaxel—skin cancer	3.59e-05	0.000597	CcSEcCtD
Cyclosporine—Anaphylactic shock—Fluorouracil—skin cancer	3.58e-05	0.000595	CcSEcCtD
Cyclosporine—Oedema—Fluorouracil—skin cancer	3.58e-05	0.000595	CcSEcCtD
Cyclosporine—Connective tissue disorder—Docetaxel—skin cancer	3.57e-05	0.000594	CcSEcCtD
Cyclosporine—Urethral disorder—Docetaxel—skin cancer	3.57e-05	0.000593	CcSEcCtD
Cyclosporine—Infection—Fluorouracil—skin cancer	3.56e-05	0.000591	CcSEcCtD
Cyclosporine—Feeling abnormal—Dactinomycin—skin cancer	3.54e-05	0.000589	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Temozolomide—skin cancer	3.54e-05	0.000589	CcSEcCtD
Cyclosporine—Insomnia—Temozolomide—skin cancer	3.51e-05	0.000584	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Dactinomycin—skin cancer	3.51e-05	0.000584	CcSEcCtD
Cyclosporine—Nervous system disorder—Fluorouracil—skin cancer	3.51e-05	0.000584	CcSEcCtD
Cyclosporine—Thrombocytopenia—Fluorouracil—skin cancer	3.51e-05	0.000583	CcSEcCtD
Cyclosporine—Visual impairment—Docetaxel—skin cancer	3.51e-05	0.000583	CcSEcCtD
Cyclosporine—Paraesthesia—Temozolomide—skin cancer	3.49e-05	0.00058	CcSEcCtD
Cyclosporine—Dyspnoea—Temozolomide—skin cancer	3.46e-05	0.000576	CcSEcCtD
Cyclosporine—Somnolence—Temozolomide—skin cancer	3.45e-05	0.000574	CcSEcCtD
Cyclosporine—Dyspepsia—Temozolomide—skin cancer	3.42e-05	0.000569	CcSEcCtD
Cyclosporine—Anorexia—Fluorouracil—skin cancer	3.41e-05	0.000567	CcSEcCtD
Cyclosporine—Abdominal pain—Dactinomycin—skin cancer	3.4e-05	0.000565	CcSEcCtD
Cyclosporine—Body temperature increased—Dactinomycin—skin cancer	3.4e-05	0.000565	CcSEcCtD
Cyclosporine—Hypersensitivity—Bleomycin—skin cancer	3.39e-05	0.000564	CcSEcCtD
Cyclosporine—Decreased appetite—Temozolomide—skin cancer	3.38e-05	0.000562	CcSEcCtD
Cyclosporine—Flushing—Docetaxel—skin cancer	3.38e-05	0.000561	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Temozolomide—skin cancer	3.35e-05	0.000558	CcSEcCtD
Cyclosporine—Fatigue—Temozolomide—skin cancer	3.35e-05	0.000557	CcSEcCtD
Cyclosporine—Pain—Temozolomide—skin cancer	3.32e-05	0.000553	CcSEcCtD
Cyclosporine—Constipation—Temozolomide—skin cancer	3.32e-05	0.000553	CcSEcCtD
Cyclosporine—Asthenia—Bleomycin—skin cancer	3.31e-05	0.00055	CcSEcCtD
Cyclosporine—Angiopathy—Docetaxel—skin cancer	3.3e-05	0.000549	CcSEcCtD
Cyclosporine—Mediastinal disorder—Docetaxel—skin cancer	3.28e-05	0.000545	CcSEcCtD
Cyclosporine—Chills—Docetaxel—skin cancer	3.26e-05	0.000543	CcSEcCtD
Cyclosporine—Musculoskeletal discomfort—Fluorouracil—skin cancer	3.26e-05	0.000542	CcSEcCtD
Cyclosporine—Pruritus—Bleomycin—skin cancer	3.26e-05	0.000542	CcSEcCtD
Cyclosporine—Arrhythmia—Docetaxel—skin cancer	3.25e-05	0.00054	CcSEcCtD
Cyclosporine—Insomnia—Fluorouracil—skin cancer	3.24e-05	0.000538	CcSEcCtD
Cyclosporine—Paraesthesia—Fluorouracil—skin cancer	3.21e-05	0.000535	CcSEcCtD
Cyclosporine—Alopecia—Docetaxel—skin cancer	3.21e-05	0.000534	CcSEcCtD
Cyclosporine—Feeling abnormal—Temozolomide—skin cancer	3.2e-05	0.000532	CcSEcCtD
Cyclosporine—Dyspnoea—Fluorouracil—skin cancer	3.19e-05	0.000531	CcSEcCtD
Cyclosporine—Mental disorder—Docetaxel—skin cancer	3.19e-05	0.00053	CcSEcCtD
Cyclosporine—Somnolence—Fluorouracil—skin cancer	3.18e-05	0.000529	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Temozolomide—skin cancer	3.18e-05	0.000528	CcSEcCtD
Cyclosporine—Malnutrition—Docetaxel—skin cancer	3.17e-05	0.000527	CcSEcCtD
Cyclosporine—Hypersensitivity—Dactinomycin—skin cancer	3.17e-05	0.000526	CcSEcCtD
Cyclosporine—ABCB1—head—skin cancer	3.16e-05	0.00121	CbGeAlD
Cyclosporine—Dyspepsia—Fluorouracil—skin cancer	3.15e-05	0.000524	CcSEcCtD
Cyclosporine—Decreased appetite—Fluorouracil—skin cancer	3.11e-05	0.000518	CcSEcCtD
Cyclosporine—Dysgeusia—Docetaxel—skin cancer	3.1e-05	0.000516	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Fluorouracil—skin cancer	3.09e-05	0.000514	CcSEcCtD
Cyclosporine—Urticaria—Temozolomide—skin cancer	3.09e-05	0.000513	CcSEcCtD
Cyclosporine—Asthenia—Dactinomycin—skin cancer	3.08e-05	0.000513	CcSEcCtD
Cyclosporine—Body temperature increased—Temozolomide—skin cancer	3.07e-05	0.000511	CcSEcCtD
Cyclosporine—Abdominal pain—Temozolomide—skin cancer	3.07e-05	0.000511	CcSEcCtD
Cyclosporine—Pain—Fluorouracil—skin cancer	3.06e-05	0.000509	CcSEcCtD
Cyclosporine—Muscle spasms—Docetaxel—skin cancer	3.04e-05	0.000506	CcSEcCtD
Cyclosporine—PPP3CA—Alzheimers Disease—TP53—skin cancer	2.99e-05	0.00272	CbGpPWpGaD
Cyclosporine—PPP3CA—G Protein Signaling Pathways—KRAS—skin cancer	2.95e-05	0.00269	CbGpPWpGaD
Cyclosporine—Feeling abnormal—Fluorouracil—skin cancer	2.95e-05	0.000491	CcSEcCtD
Cyclosporine—Diarrhoea—Dactinomycin—skin cancer	2.94e-05	0.000489	CcSEcCtD
Cyclosporine—Vomiting—Bleomycin—skin cancer	2.93e-05	0.000487	CcSEcCtD
Cyclosporine—Anaemia—Docetaxel—skin cancer	2.93e-05	0.000487	CcSEcCtD
Cyclosporine—Rash—Bleomycin—skin cancer	2.9e-05	0.000483	CcSEcCtD
Cyclosporine—Dermatitis—Bleomycin—skin cancer	2.9e-05	0.000483	CcSEcCtD
Cyclosporine—PPIA—Cell surface interactions at the vascular wall—HRAS—skin cancer	2.87e-05	0.00262	CbGpPWpGaD
Cyclosporine—Hypersensitivity—Temozolomide—skin cancer	2.86e-05	0.000476	CcSEcCtD
Cyclosporine—ABCC1—Arachidonic acid metabolism—PTGS2—skin cancer	2.86e-05	0.0026	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	2.85e-05	0.00259	CbGpPWpGaD
Cyclosporine—Urticaria—Fluorouracil—skin cancer	2.84e-05	0.000473	CcSEcCtD
Cyclosporine—Leukopenia—Docetaxel—skin cancer	2.83e-05	0.000471	CcSEcCtD
Cyclosporine—Body temperature increased—Fluorouracil—skin cancer	2.83e-05	0.000471	CcSEcCtD
Cyclosporine—FKBP1A—Spinal Cord Injury—PTGS2—skin cancer	2.83e-05	0.00257	CbGpPWpGaD
Cyclosporine—PPIA—Disease—CSPG4—skin cancer	2.8e-05	0.00255	CbGpPWpGaD
Cyclosporine—Asthenia—Temozolomide—skin cancer	2.79e-05	0.000464	CcSEcCtD
Cyclosporine—Cough—Docetaxel—skin cancer	2.76e-05	0.000459	CcSEcCtD
Cyclosporine—Pruritus—Temozolomide—skin cancer	2.75e-05	0.000457	CcSEcCtD
Cyclosporine—Convulsion—Docetaxel—skin cancer	2.74e-05	0.000456	CcSEcCtD
Cyclosporine—Nausea—Bleomycin—skin cancer	2.74e-05	0.000455	CcSEcCtD
Cyclosporine—ABCC3—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	2.73e-05	0.00249	CbGpPWpGaD
Cyclosporine—Hypertension—Docetaxel—skin cancer	2.73e-05	0.000455	CcSEcCtD
Cyclosporine—Vomiting—Dactinomycin—skin cancer	2.73e-05	0.000454	CcSEcCtD
Cyclosporine—PPP3CA—C-MYB transcription factor network—HRAS—skin cancer	2.72e-05	0.00248	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—TLR7—skin cancer	2.71e-05	0.00247	CbGpPWpGaD
Cyclosporine—Rash—Dactinomycin—skin cancer	2.71e-05	0.00045	CcSEcCtD
Cyclosporine—Chest pain—Docetaxel—skin cancer	2.7e-05	0.000448	CcSEcCtD
Cyclosporine—Arthralgia—Docetaxel—skin cancer	2.7e-05	0.000448	CcSEcCtD
Cyclosporine—Myalgia—Docetaxel—skin cancer	2.7e-05	0.000448	CcSEcCtD
Cyclosporine—SLC10A2—Metabolism—CSPG4—skin cancer	2.7e-05	0.00245	CbGpPWpGaD
Cyclosporine—FKBP1A—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	2.69e-05	0.00245	CbGpPWpGaD
Cyclosporine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—skin cancer	2.68e-05	0.000445	CcSEcCtD
Cyclosporine—Diarrhoea—Temozolomide—skin cancer	2.66e-05	0.000442	CcSEcCtD
Cyclosporine—Hypersensitivity—Fluorouracil—skin cancer	2.64e-05	0.000439	CcSEcCtD
Cyclosporine—Dry mouth—Docetaxel—skin cancer	2.64e-05	0.000438	CcSEcCtD
Cyclosporine—PPP3CA—Signaling by GPCR—MC1R—skin cancer	2.63e-05	0.00239	CbGpPWpGaD
Cyclosporine—Confusional state—Docetaxel—skin cancer	2.61e-05	0.000433	CcSEcCtD
Cyclosporine—PPP3CA—Signaling by Wnt—TERT—skin cancer	2.59e-05	0.00235	CbGpPWpGaD
Cyclosporine—Anaphylactic shock—Docetaxel—skin cancer	2.58e-05	0.00043	CcSEcCtD
Cyclosporine—Oedema—Docetaxel—skin cancer	2.58e-05	0.00043	CcSEcCtD
Cyclosporine—FKBP4—Cellular responses to stress—TP53—skin cancer	2.58e-05	0.00235	CbGpPWpGaD
Cyclosporine—Dizziness—Temozolomide—skin cancer	2.57e-05	0.000427	CcSEcCtD
Cyclosporine—Infection—Docetaxel—skin cancer	2.57e-05	0.000427	CcSEcCtD
Cyclosporine—Nausea—Dactinomycin—skin cancer	2.55e-05	0.000424	CcSEcCtD
Cyclosporine—Nervous system disorder—Docetaxel—skin cancer	2.53e-05	0.000421	CcSEcCtD
Cyclosporine—Pruritus—Fluorouracil—skin cancer	2.53e-05	0.000421	CcSEcCtD
Cyclosporine—Thrombocytopenia—Docetaxel—skin cancer	2.53e-05	0.000421	CcSEcCtD
Cyclosporine—PPP3CA—G Protein Signaling Pathways—HRAS—skin cancer	2.51e-05	0.00228	CbGpPWpGaD
Cyclosporine—Skin disorder—Docetaxel—skin cancer	2.51e-05	0.000417	CcSEcCtD
Cyclosporine—Vomiting—Temozolomide—skin cancer	2.47e-05	0.000411	CcSEcCtD
Cyclosporine—ABCC3—Transmembrane transport of small molecules—SLC12A2—skin cancer	2.46e-05	0.00224	CbGpPWpGaD
Cyclosporine—Anorexia—Docetaxel—skin cancer	2.46e-05	0.00041	CcSEcCtD
Cyclosporine—Rash—Temozolomide—skin cancer	2.45e-05	0.000407	CcSEcCtD
Cyclosporine—Diarrhoea—Fluorouracil—skin cancer	2.45e-05	0.000407	CcSEcCtD
Cyclosporine—Dermatitis—Temozolomide—skin cancer	2.45e-05	0.000407	CcSEcCtD
Cyclosporine—Headache—Temozolomide—skin cancer	2.43e-05	0.000405	CcSEcCtD
Cyclosporine—PPP3CA—Innate Immune System—FOXO4—skin cancer	2.4e-05	0.00218	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	2.38e-05	0.00217	CbGpPWpGaD
Cyclosporine—Dizziness—Fluorouracil—skin cancer	2.37e-05	0.000394	CcSEcCtD
Cyclosporine—FKBP4—Cellular responses to stress—IL6—skin cancer	2.36e-05	0.00215	CbGpPWpGaD
Cyclosporine—Musculoskeletal discomfort—Docetaxel—skin cancer	2.35e-05	0.000391	CcSEcCtD
Cyclosporine—Insomnia—Docetaxel—skin cancer	2.34e-05	0.000389	CcSEcCtD
Cyclosporine—PPP3CA—Disease—CSPG4—skin cancer	2.33e-05	0.00212	CbGpPWpGaD
Cyclosporine—Paraesthesia—Docetaxel—skin cancer	2.32e-05	0.000386	CcSEcCtD
Cyclosporine—Nausea—Temozolomide—skin cancer	2.31e-05	0.000384	CcSEcCtD
Cyclosporine—Dyspnoea—Docetaxel—skin cancer	2.3e-05	0.000383	CcSEcCtD
Cyclosporine—Somnolence—Docetaxel—skin cancer	2.3e-05	0.000382	CcSEcCtD
Cyclosporine—Vomiting—Fluorouracil—skin cancer	2.28e-05	0.000379	CcSEcCtD
Cyclosporine—Dyspepsia—Docetaxel—skin cancer	2.27e-05	0.000378	CcSEcCtD
Cyclosporine—Rash—Fluorouracil—skin cancer	2.26e-05	0.000375	CcSEcCtD
Cyclosporine—Dermatitis—Fluorouracil—skin cancer	2.26e-05	0.000375	CcSEcCtD
Cyclosporine—Decreased appetite—Docetaxel—skin cancer	2.25e-05	0.000374	CcSEcCtD
Cyclosporine—Headache—Fluorouracil—skin cancer	2.24e-05	0.000373	CcSEcCtD
Cyclosporine—Gastrointestinal disorder—Docetaxel—skin cancer	2.23e-05	0.000371	CcSEcCtD
Cyclosporine—Fatigue—Docetaxel—skin cancer	2.23e-05	0.00037	CcSEcCtD
Cyclosporine—ABCB1—lymph node—skin cancer	2.21e-05	0.000845	CbGeAlD
Cyclosporine—Pain—Docetaxel—skin cancer	2.21e-05	0.000367	CcSEcCtD
Cyclosporine—Constipation—Docetaxel—skin cancer	2.21e-05	0.000367	CcSEcCtD
Cyclosporine—PPP3CA—Spinal Cord Injury—TP53—skin cancer	2.17e-05	0.00197	CbGpPWpGaD
Cyclosporine—SLC10A1—Metabolism—PLIN2—skin cancer	2.15e-05	0.00196	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—PTCH2—skin cancer	2.15e-05	0.00196	CbGpPWpGaD
Cyclosporine—SLCO1A2—Transmembrane transport of small molecules—SLC12A2—skin cancer	2.15e-05	0.00195	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	2.14e-05	0.00195	CbGpPWpGaD
Cyclosporine—PPP3CA—MAPK Signaling Pathway—NRAS—skin cancer	2.14e-05	0.00195	CbGpPWpGaD
Cyclosporine—Feeling abnormal—Docetaxel—skin cancer	2.13e-05	0.000354	CcSEcCtD
Cyclosporine—Nausea—Fluorouracil—skin cancer	2.13e-05	0.000354	CcSEcCtD
Cyclosporine—Gastrointestinal pain—Docetaxel—skin cancer	2.11e-05	0.000351	CcSEcCtD
Cyclosporine—ABCG2—Fluoropyrimidine Activity—TP53—skin cancer	2.09e-05	0.0019	CbGpPWpGaD
Cyclosporine—PPP3CA—Fc epsilon receptor (FCERI) signaling—NRAS—skin cancer	2.05e-05	0.00187	CbGpPWpGaD
Cyclosporine—Abdominal pain—Docetaxel—skin cancer	2.04e-05	0.00034	CcSEcCtD
Cyclosporine—Body temperature increased—Docetaxel—skin cancer	2.04e-05	0.00034	CcSEcCtD
Cyclosporine—SLCO1B1—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	2.04e-05	0.00185	CbGpPWpGaD
Cyclosporine—SLC22A6—Transmembrane transport of small molecules—SLC12A2—skin cancer	2.02e-05	0.00184	CbGpPWpGaD
Cyclosporine—PPP3CA—Spinal Cord Injury—IL6—skin cancer	1.99e-05	0.00181	CbGpPWpGaD
Cyclosporine—ABCC2—Transmembrane transport of small molecules—SLC12A2—skin cancer	1.95e-05	0.00178	CbGpPWpGaD
Cyclosporine—ABCC1—Transmembrane transport of small molecules—SLC12A2—skin cancer	1.93e-05	0.00176	CbGpPWpGaD
Cyclosporine—FKBP1A—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	1.92e-05	0.00175	CbGpPWpGaD
Cyclosporine—Hypersensitivity—Docetaxel—skin cancer	1.9e-05	0.000317	CcSEcCtD
Cyclosporine—PPIA—Disease—ENO2—skin cancer	1.9e-05	0.00173	CbGpPWpGaD
Cyclosporine—PPIA—Disease—SHH—skin cancer	1.9e-05	0.00173	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling by GPCR—SHH—skin cancer	1.88e-05	0.00171	CbGpPWpGaD
Cyclosporine—Asthenia—Docetaxel—skin cancer	1.85e-05	0.000308	CcSEcCtD
Cyclosporine—PPP3CA—MAPK Signaling Pathway—KRAS—skin cancer	1.84e-05	0.00167	CbGpPWpGaD
Cyclosporine—ABCC1—Defective AMN causes hereditary megaloblastic anemia 1—PTGS2—skin cancer	1.84e-05	0.00167	CbGpPWpGaD
Cyclosporine—SLCO1B1—Transmembrane transport of small molecules—SLC12A2—skin cancer	1.84e-05	0.00167	CbGpPWpGaD
Cyclosporine—SLC10A2—Metabolism—ENO2—skin cancer	1.83e-05	0.00167	CbGpPWpGaD
Cyclosporine—Pruritus—Docetaxel—skin cancer	1.83e-05	0.000304	CcSEcCtD
Cyclosporine—FKBP1A—Disease—CSPG4—skin cancer	1.8e-05	0.00164	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling by GPCR—PTCH1—skin cancer	1.78e-05	0.00162	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling by GPCR—SMO—skin cancer	1.78e-05	0.00162	CbGpPWpGaD
Cyclosporine—Diarrhoea—Docetaxel—skin cancer	1.77e-05	0.000294	CcSEcCtD
Cyclosporine—PPP3CA—Fc epsilon receptor (FCERI) signaling—KRAS—skin cancer	1.77e-05	0.00161	CbGpPWpGaD
Cyclosporine—SLC10A1—Metabolism—CSPG4—skin cancer	1.74e-05	0.00158	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling by GPCR—PTGER4—skin cancer	1.73e-05	0.00157	CbGpPWpGaD
Cyclosporine—Dizziness—Docetaxel—skin cancer	1.71e-05	0.000284	CcSEcCtD
Cyclosporine—ABCB1—HIF-1-alpha transcription factor network—TERT—skin cancer	1.7e-05	0.00155	CbGpPWpGaD
Cyclosporine—ABCG2—Transmembrane transport of small molecules—SLC12A2—skin cancer	1.7e-05	0.00155	CbGpPWpGaD
Cyclosporine—FKBP1A—Spinal Cord Injury—TP53—skin cancer	1.68e-05	0.00153	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—PTCH2—skin cancer	1.67e-05	0.00152	CbGpPWpGaD
Cyclosporine—Vomiting—Docetaxel—skin cancer	1.64e-05	0.000273	CcSEcCtD
Cyclosporine—PPP3CA—MAPK Signaling Pathway—TP53—skin cancer	1.64e-05	0.00149	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—GLI2—skin cancer	1.63e-05	0.00148	CbGpPWpGaD
Cyclosporine—Rash—Docetaxel—skin cancer	1.63e-05	0.000271	CcSEcCtD
Cyclosporine—Dermatitis—Docetaxel—skin cancer	1.63e-05	0.000271	CcSEcCtD
Cyclosporine—Headache—Docetaxel—skin cancer	1.62e-05	0.000269	CcSEcCtD
Cyclosporine—PPP3CA—Disease—SHH—skin cancer	1.58e-05	0.00144	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—ENO2—skin cancer	1.58e-05	0.00144	CbGpPWpGaD
Cyclosporine—CYP2C8—Arachidonic acid metabolism—PTGS2—skin cancer	1.56e-05	0.00142	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—MC1R—skin cancer	1.55e-05	0.00141	CbGpPWpGaD
Cyclosporine—PPIA—Disease—FOXO4—skin cancer	1.55e-05	0.00141	CbGpPWpGaD
Cyclosporine—FKBP1A—Spinal Cord Injury—IL6—skin cancer	1.54e-05	0.0014	CbGpPWpGaD
Cyclosporine—Nausea—Docetaxel—skin cancer	1.53e-05	0.000255	CcSEcCtD
Cyclosporine—PPP3CA—Signaling Pathways—GLI1—skin cancer	1.53e-05	0.00139	CbGpPWpGaD
Cyclosporine—PPP3CA—Fc epsilon receptor (FCERI) signaling—HRAS—skin cancer	1.5e-05	0.00137	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—SUFU—skin cancer	1.45e-05	0.00132	CbGpPWpGaD
Cyclosporine—PPP3CA—Fc epsilon receptor (FCERI) signaling—IL6—skin cancer	1.44e-05	0.00131	CbGpPWpGaD
Cyclosporine—SLC10A2—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.43e-05	0.0013	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—FOXO4—skin cancer	1.4e-05	0.00127	CbGpPWpGaD
Cyclosporine—CYP2C19—Arachidonic acid metabolism—PTGS2—skin cancer	1.39e-05	0.00127	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—SHH—skin cancer	1.34e-05	0.00122	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—FOXO4—skin cancer	1.29e-05	0.00117	CbGpPWpGaD
Cyclosporine—FKBP1A—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	1.29e-05	0.00117	CbGpPWpGaD
Cyclosporine—CYP2C9—Arachidonic acid metabolism—PTGS2—skin cancer	1.27e-05	0.00116	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—PLIN2—skin cancer	1.27e-05	0.00116	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—SMO—skin cancer	1.27e-05	0.00115	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—GLI2—skin cancer	1.26e-05	0.00115	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—ENO2—skin cancer	1.23e-05	0.00112	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—SHH—skin cancer	1.23e-05	0.00112	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—PLIN2—skin cancer	1.22e-05	0.00111	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—MC1R—skin cancer	1.21e-05	0.0011	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—GLI1—skin cancer	1.19e-05	0.00108	CbGpPWpGaD
Cyclosporine—SLC10A1—Metabolism—ENO2—skin cancer	1.18e-05	0.00107	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	1.17e-05	0.00106	CbGpPWpGaD
Cyclosporine—FKBP1A—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	1.14e-05	0.00104	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—SUFU—skin cancer	1.13e-05	0.00102	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—SHH—skin cancer	1.11e-05	0.00101	CbGpPWpGaD
Cyclosporine—PPIA—Disease—ERCC2—skin cancer	1.11e-05	0.00101	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—RASA1—skin cancer	1.1e-05	0.001	CbGpPWpGaD
Cyclosporine—PPIA—Hemostasis—NRAS—skin cancer	1.07e-05	0.000969	CbGpPWpGaD
Cyclosporine—SLC10A2—Metabolism—ERCC2—skin cancer	1.06e-05	0.000968	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—PLIN2—skin cancer	1.06e-05	0.000965	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—PTCH1—skin cancer	1.05e-05	0.000955	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—SMO—skin cancer	1.05e-05	0.000955	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	1.04e-05	0.00095	CbGpPWpGaD
Cyclosporine—PPIA—Disease—TERT—skin cancer	1.04e-05	0.000943	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—CSPG4—skin cancer	1.02e-05	0.000931	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—PTGER4—skin cancer	1.02e-05	0.00093	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—FOXO4—skin cancer	1e-05	0.00091	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—CSPG4—skin cancer	9.81e-06	0.000893	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PLIN2—skin cancer	9.54e-06	0.000868	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PLIN2—skin cancer	9.52e-06	0.000866	CbGpPWpGaD
Cyclosporine—SLC10A1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	9.23e-06	0.00084	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—ERCC2—skin cancer	9.19e-06	0.000836	CbGpPWpGaD
Cyclosporine—ABCB1—Transmembrane transport of small molecules—SLC12A2—skin cancer	9.19e-06	0.000836	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—CSPG4—skin cancer	9.18e-06	0.000835	CbGpPWpGaD
Cyclosporine—PPIA—Hemostasis—KRAS—skin cancer	9.17e-06	0.000834	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PLIN2—skin cancer	9.07e-06	0.000825	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—FOXO4—skin cancer	9.03e-06	0.000821	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—TERT—skin cancer	8.61e-06	0.000784	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—SHH—skin cancer	8.59e-06	0.000781	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—CSPG4—skin cancer	8.55e-06	0.000778	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—RASA1—skin cancer	8.53e-06	0.000776	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PLIN2—skin cancer	8.4e-06	0.000764	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PLIN2—skin cancer	8.32e-06	0.000757	CbGpPWpGaD
Cyclosporine—PPIA—Disease—BRAF—skin cancer	8.21e-06	0.000747	CbGpPWpGaD
Cyclosporine—PPIA—Hemostasis—TP53—skin cancer	8.15e-06	0.000741	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—PTCH1—skin cancer	8.14e-06	0.000741	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—SMO—skin cancer	8.14e-06	0.000741	CbGpPWpGaD
Cyclosporine—PPP3CA—Innate Immune System—NRAS—skin cancer	7.97e-06	0.000725	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—PTGER4—skin cancer	7.93e-06	0.000721	CbGpPWpGaD
Cyclosporine—PPIA—Hemostasis—HRAS—skin cancer	7.79e-06	0.000709	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—CSPG4—skin cancer	7.69e-06	0.0007	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—CSPG4—skin cancer	7.31e-06	0.000665	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—ERCC2—skin cancer	7.12e-06	0.000648	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—FOXO4—skin cancer	7e-06	0.000637	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—ENO2—skin cancer	6.96e-06	0.000633	CbGpPWpGaD
Cyclosporine—PPP3CA—Innate Immune System—KRAS—skin cancer	6.86e-06	0.000624	CbGpPWpGaD
Cyclosporine—SLC10A1—Metabolism—ERCC2—skin cancer	6.86e-06	0.000624	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—BRAF—skin cancer	6.82e-06	0.000621	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—CSPG4—skin cancer	6.77e-06	0.000616	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—CSPG4—skin cancer	6.71e-06	0.00061	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—TERT—skin cancer	6.68e-06	0.000608	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—ENO2—skin cancer	6.67e-06	0.000607	CbGpPWpGaD
Cyclosporine—PPIA—Disease—PTGS2—skin cancer	6.63e-06	0.000603	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—skin cancer	6.52e-06	0.000593	CbGpPWpGaD
Cyclosporine—SLC10A2—Metabolism—PTGS2—skin cancer	6.38e-06	0.000581	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—SHH—skin cancer	6.24e-06	0.000568	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—ENO2—skin cancer	6.24e-06	0.000568	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—TERT—skin cancer	6.03e-06	0.000549	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PLIN2—skin cancer	6.02e-06	0.000547	CbGpPWpGaD
Cyclosporine—PPP3CA—Innate Immune System—HRAS—skin cancer	5.83e-06	0.000531	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—ENO2—skin cancer	5.81e-06	0.000529	CbGpPWpGaD
Cyclosporine—PPP3CA—Innate Immune System—IL6—skin cancer	5.58e-06	0.000508	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—PTGS2—skin cancer	5.51e-06	0.000501	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	5.44e-06	0.000495	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—BRAF—skin cancer	5.29e-06	0.000481	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—ENO2—skin cancer	5.23e-06	0.000476	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	5.22e-06	0.000475	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PLIN2—skin cancer	5.21e-06	0.000474	CbGpPWpGaD
Cyclosporine—PPIA—Disease—NRAS—skin cancer	5.16e-06	0.000469	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—FOXO4—skin cancer	5.09e-06	0.000463	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling by GPCR—NRAS—skin cancer	5.08e-06	0.000462	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—ENO2—skin cancer	4.97e-06	0.000452	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—CSPG4—skin cancer	4.85e-06	0.000441	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—BRAF—skin cancer	4.78e-06	0.000435	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—TERT—skin cancer	4.68e-06	0.000425	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—skin cancer	4.66e-06	0.000424	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PLIN2—skin cancer	4.65e-06	0.000423	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—NRAS—skin cancer	4.64e-06	0.000422	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—ENO2—skin cancer	4.6e-06	0.000418	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—ENO2—skin cancer	4.56e-06	0.000415	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	4.54e-06	0.000413	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PLIN2—skin cancer	4.54e-06	0.000413	CbGpPWpGaD
Cyclosporine—PPIA—Disease—KRAS—skin cancer	4.44e-06	0.000404	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling by GPCR—KRAS—skin cancer	4.37e-06	0.000398	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—NRAS—skin cancer	4.29e-06	0.00039	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PLIN2—skin cancer	4.28e-06	0.000389	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—PTGS2—skin cancer	4.27e-06	0.000389	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PLIN2—skin cancer	4.24e-06	0.000386	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—CSPG4—skin cancer	4.2e-06	0.000382	CbGpPWpGaD
Cyclosporine—SLC10A1—Metabolism—PTGS2—skin cancer	4.11e-06	0.000374	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	4.09e-06	0.000372	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—ERCC2—skin cancer	4.04e-06	0.000368	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—KRAS—skin cancer	4e-06	0.000364	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	3.89e-06	0.000353	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—ERCC2—skin cancer	3.88e-06	0.000353	CbGpPWpGaD
Cyclosporine—PPIA—Disease—HRAS—skin cancer	3.77e-06	0.000343	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—CSPG4—skin cancer	3.75e-06	0.000341	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling by GPCR—HRAS—skin cancer	3.72e-06	0.000338	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—BRAF—skin cancer	3.7e-06	0.000337	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—KRAS—skin cancer	3.69e-06	0.000336	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—CSPG4—skin cancer	3.66e-06	0.000333	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—ERCC2—skin cancer	3.63e-06	0.00033	CbGpPWpGaD
Cyclosporine—PPIA—Disease—IL6—skin cancer	3.61e-06	0.000329	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling by GPCR—IL6—skin cancer	3.56e-06	0.000324	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—CSPG4—skin cancer	3.45e-06	0.000314	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—CSPG4—skin cancer	3.42e-06	0.000311	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—TERT—skin cancer	3.4e-06	0.000309	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—HRAS—skin cancer	3.4e-06	0.000309	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—ERCC2—skin cancer	3.37e-06	0.000307	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—NRAS—skin cancer	3.32e-06	0.000302	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—ENO2—skin cancer	3.3e-06	0.0003	CbGpPWpGaD
Cyclosporine—PPP3CA—Immune System—IL6—skin cancer	3.25e-06	0.000296	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—HRAS—skin cancer	3.14e-06	0.000285	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—skin cancer	3.12e-06	0.000284	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—ERCC2—skin cancer	3.04e-06	0.000276	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—NRAS—skin cancer	3e-06	0.000273	CbGpPWpGaD
Cyclosporine—PPP3CA—Disease—IL6—skin cancer	3e-06	0.000273	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—ERCC2—skin cancer	2.89e-06	0.000263	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—KRAS—skin cancer	2.86e-06	0.00026	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—ENO2—skin cancer	2.85e-06	0.00026	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PLIN2—skin cancer	2.8e-06	0.000254	CbGpPWpGaD
Cyclosporine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—skin cancer	2.77e-06	0.000252	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—BRAF—skin cancer	2.69e-06	0.000245	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—ERCC2—skin cancer	2.67e-06	0.000243	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—ERCC2—skin cancer	2.65e-06	0.000241	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—KRAS—skin cancer	2.58e-06	0.000235	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—ENO2—skin cancer	2.55e-06	0.000232	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—ENO2—skin cancer	2.49e-06	0.000226	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—HRAS—skin cancer	2.43e-06	0.000221	CbGpPWpGaD
Cyclosporine—ABCB11—Metabolism—PTGS2—skin cancer	2.42e-06	0.00022	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—ENO2—skin cancer	2.34e-06	0.000213	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—NRAS—skin cancer	2.33e-06	0.000212	CbGpPWpGaD
Cyclosporine—FKBP1A—Disease—IL6—skin cancer	2.33e-06	0.000212	CbGpPWpGaD
Cyclosporine—ABCC3—Metabolism—PTGS2—skin cancer	2.32e-06	0.000211	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—ENO2—skin cancer	2.32e-06	0.000211	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—TP53—skin cancer	2.3e-06	0.000209	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—CSPG4—skin cancer	2.25e-06	0.000205	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	2.23e-06	0.000203	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—HRAS—skin cancer	2.2e-06	0.0002	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—PTGS2—skin cancer	2.17e-06	0.000198	CbGpPWpGaD
Cyclosporine—PPP3CA—Signaling Pathways—IL6—skin cancer	2.1e-06	0.000191	CbGpPWpGaD
Cyclosporine—SLCO1A2—Metabolism—PTGS2—skin cancer	2.02e-06	0.000184	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—KRAS—skin cancer	2e-06	0.000182	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.99e-06	0.000181	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—ERCC2—skin cancer	1.91e-06	0.000174	CbGpPWpGaD
Cyclosporine—ABCC1—Metabolism—PTGS2—skin cancer	1.82e-06	0.000166	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—skin cancer	1.82e-06	0.000165	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—TP53—skin cancer	1.78e-06	0.000162	CbGpPWpGaD
Cyclosporine—SLCO1B1—Metabolism—PTGS2—skin cancer	1.73e-06	0.000157	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—HRAS—skin cancer	1.7e-06	0.000155	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—NRAS—skin cancer	1.69e-06	0.000154	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—ERCC2—skin cancer	1.66e-06	0.000151	CbGpPWpGaD
Cyclosporine—FKBP1A—Signaling Pathways—IL6—skin cancer	1.63e-06	0.000148	CbGpPWpGaD
Cyclosporine—ABCG2—Metabolism—PTGS2—skin cancer	1.6e-06	0.000146	CbGpPWpGaD
Cyclosporine—CYP3A7—Metabolism—PTGS2—skin cancer	1.59e-06	0.000144	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—ENO2—skin cancer	1.53e-06	0.000139	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—ERCC2—skin cancer	1.48e-06	0.000135	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—KRAS—skin cancer	1.46e-06	0.000132	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—ERCC2—skin cancer	1.44e-06	0.000131	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—ERCC2—skin cancer	1.36e-06	0.000124	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—ERCC2—skin cancer	1.35e-06	0.000123	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—HRAS—skin cancer	1.24e-06	0.000113	CbGpPWpGaD
Cyclosporine—ABCC1—Disease—IL6—skin cancer	1.18e-06	0.000108	CbGpPWpGaD
Cyclosporine—CYP3A5—Metabolism—PTGS2—skin cancer	1.15e-06	0.000104	CbGpPWpGaD
Cyclosporine—CYP2C8—Metabolism—PTGS2—skin cancer	9.94e-07	9.05e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—ERCC2—skin cancer	8.9e-07	8.1e-05	CbGpPWpGaD
Cyclosporine—CYP2C19—Metabolism—PTGS2—skin cancer	8.87e-07	8.07e-05	CbGpPWpGaD
Cyclosporine—ABCB1—Metabolism—PTGS2—skin cancer	8.66e-07	7.88e-05	CbGpPWpGaD
Cyclosporine—CYP2D6—Metabolism—PTGS2—skin cancer	8.16e-07	7.43e-05	CbGpPWpGaD
Cyclosporine—CYP2C9—Metabolism—PTGS2—skin cancer	8.09e-07	7.36e-05	CbGpPWpGaD
Cyclosporine—CYP3A4—Metabolism—PTGS2—skin cancer	5.34e-07	4.86e-05	CbGpPWpGaD
